Libin Wei

1.9k total citations · 1 hit paper
48 papers, 1.4k citations indexed

About

Libin Wei is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Libin Wei has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 17 papers in Cancer Research and 15 papers in Pharmacology. Recurrent topics in Libin Wei's work include Cancer, Hypoxia, and Metabolism (16 papers), Flavonoids in Medical Research (15 papers) and Cancer-related Molecular Pathways (8 papers). Libin Wei is often cited by papers focused on Cancer, Hypoxia, and Metabolism (16 papers), Flavonoids in Medical Research (15 papers) and Cancer-related Molecular Pathways (8 papers). Libin Wei collaborates with scholars based in China, United States and Norway. Libin Wei's co-authors include Qinglong Guo, Na Lu, Zhiyu Li, Jingyue Yao, Qinsheng Dai, Yongjian Guo, Yuxin Zhou, Ye Xu, Qidong You and Yuxin Zhou and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Free Radical Biology and Medicine.

In The Last Decade

Libin Wei

47 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma

2021 155 citations Jingyue Yao, Ye Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Libin Wei China	26	868	354	333	216	182	48	1.4k
Soyeon Jeong South Korea	24	734 0.8×	318 0.9×	300 0.9×	292 1.4×	196 1.1×	46	1.5k
Jian Huang China	25	883 1.0×	213 0.6×	270 0.8×	212 1.0×	161 0.9×	92	1.8k
Hyeonseok Ko South Korea	25	1.1k 1.2×	248 0.7×	171 0.5×	154 0.7×	270 1.5×	38	1.7k
Chuan‐Ming Xie China	18	738 0.9×	185 0.5×	176 0.5×	228 1.1×	187 1.0×	42	1.3k
Shu‐Huei Tsai Taiwan	19	822 0.9×	192 0.5×	252 0.8×	202 0.9×	177 1.0×	28	1.7k
Wei-Jiunn Lee Taiwan	24	999 1.2×	413 1.2×	173 0.5×	117 0.5×	311 1.7×	42	1.6k
Young‐Joo Kim South Korea	23	1.0k 1.2×	199 0.6×	205 0.6×	158 0.7×	130 0.7×	55	1.6k
Khuloud Bajbouj United Arab Emirates	23	866 1.0×	247 0.7×	200 0.6×	121 0.6×	375 2.1×	66	1.8k
Guangwen Shu China	24	919 1.1×	238 0.7×	136 0.4×	185 0.9×	164 0.9×	41	1.5k
Jun Hee Lim South Korea	22	1.1k 1.2×	202 0.6×	200 0.6×	199 0.9×	240 1.3×	38	1.7k

Countries citing papers authored by Libin Wei

Since Specialization

Citations

This map shows the geographic impact of Libin Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libin Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libin Wei more than expected).

Fields of papers citing papers by Libin Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libin Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libin Wei. The network helps show where Libin Wei may publish in the future.

Co-authorship network of co-authors of Libin Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Libin Wei. A scholar is included among the top collaborators of Libin Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libin Wei. Libin Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xuefeng, Ruitian Zhang, Yuening Sun, et al.. (2023). AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations. Cancer Letters. 566. 216240–216240. 14 indexed citations

Liu, Jian, Yongjian Guo, Ruitian Zhang, et al.. (2023). Inhibition of TRPV4 remodels single cell polarity and suppresses the metastasis of hepatocellular carcinoma. Cell Death and Disease. 14(6). 379–379. 10 indexed citations

Guo, Yongjian, Yuening Sun, Wenjing Guo, et al.. (2023). Inhibition of mitochondrial fusion via SIRT1/PDK2/PARL axis breaks mitochondrial metabolic plasticity and sensitizes cancer cells to glucose restriction therapy. Biomedicine & Pharmacotherapy. 166. 115342–115342. 3 indexed citations

Zhao, Hui, Chenhong Zhu, Chenchen Li, et al.. (2023). Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma. Biomedicine & Pharmacotherapy. 165. 115096–115096. 10 indexed citations

Guo, Yongjian, et al.. (2021). FV-429 enhances the efficacy of paclitaxel in NSCLC by reprogramming HIF-1α-modulated FattyAcid metabolism. Chemico-Biological Interactions. 350. 109702–109702. 12 indexed citations

Yao, Jingyue, Shu Xu, Yuening Sun, et al.. (2021). Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling. Acta Pharmacologica Sinica. 43(4). 1033–1045. 41 indexed citations

Yang, Lin, Zihao He, Jingyue Yao, et al.. (2018). Regulation of AMPK-related glycolipid metabolism imbalances redox homeostasis and inhibits anchorage independent growth in human breast cancer cells. Redox Biology. 17. 180–191. 43 indexed citations

Wei, Libin, Yuyuan Yao, Kai Zhao, et al.. (2016). Oroxylin A inhibits invasion and migration through suppressing ERK/GSK‐3β signaling in snail‐expressing non‐small‐cell lung cancer cells. Molecular Carcinogenesis. 55(12). 2121–2134. 32 indexed citations

Huang, Yujie, Kai Zhao, Yang Hu, et al.. (2015). Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β‐catenin pathway. Molecular Carcinogenesis. 55(11). 1598–1612. 42 indexed citations

10.

Dai, Qinsheng, Qian Yin, Libin Wei, et al.. (2015). Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia‐inducible factor‐1 in human hepatoma HepG2 cells. Molecular Carcinogenesis. 55(8). 1275–1289. 32 indexed citations

11.

Zhou, Mi, Xiuming Song, Yujie Huang, et al.. (2014). Wogonin inhibits H2O2-induced angiogenesis via suppressing PI3K/Akt/NF-κB signaling pathway. Vascular Pharmacology. 60(3). 110–119. 39 indexed citations

12.

Zhao, Kai, Libin Wei, Hui Hui, et al.. (2014). Wogonin Suppresses Melanoma Cell B16-F10 Invasion and Migration by Inhibiting Ras-Medicated Pathways. PLoS ONE. 9(9). e106458–e106458. 32 indexed citations

13.

Dai, Qinsheng, Wei Liu, Libin Wei, et al.. (2013). Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells. The International Journal of Biochemistry & Cell Biology. 45(7). 1468–1478. 33 indexed citations

14.

Song, Xiuming, Jing Yao, Fei Wang, et al.. (2013). Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. Toxicology and Applied Pharmacology. 271(2). 144–155. 66 indexed citations

15.

Wang, Xiaocen, Wenzhi Ren, Ying Nie, et al.. (2013). A novel watery diarrhoea caused by the co-infection of neonatal piglets with Clostridium perfringens type A and Escherichia coli (K88, 987P). The Veterinary Journal. 197(3). 812–816. 10 indexed citations

16.

Zhou, Yuxin, Na Lu, Haiwei Zhang, et al.. (2013). HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro. European Journal of Pharmaceutical Sciences. 49(4). 649–658. 8 indexed citations

17.

Wei, Libin, Qinsheng Dai, Yuxin Zhou, et al.. (2013). Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(6). 3835–3845. 40 indexed citations

18.

Xu, Min, Na Lu, Haiwei Zhang, et al.. (2012). Activation of the unfolded protein response contributed to the selective cytotoxicity of oroxylin A in human hepatocellular carcinoma HepG2 cells. Toxicology Letters. 212(2). 113–125. 27 indexed citations

19.

Wang, Fei, Xiuming Song, Mi Zhou, et al.. (2012). Wogonin inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of caveolin-1. Toxicology. 305. 10–19. 18 indexed citations

20.

Li, Liwen, Na Lu, Qinsheng Dai, et al.. (2011). GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells. European Journal of Pharmacology. 670(1). 13–21. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact